Medicine and Dentistry
Hepatocellular Carcinoma
100%
Growth Disorder
100%
microRNA
100%
Sorafenib
100%
Phosphoinositide 3-Kinase
18%
Protein Kinase B
18%
In Vitro
9%
Protein Tyrosine Kinase
9%
Therapy Effect
9%
Cancer Cell
9%
Methanol Extraction Residue
9%
Signal Transduction Pathway
9%
Hepatocellular Carcinoma Cell Line
9%
Cell Invasion
9%
Hepatology
9%
Cell Migration
9%
Tumor Suppressor Protein
9%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
microRNA
100%
Sorafenib
100%
Growth Disorder
100%
Phosphatidylinositol 3 Kinase
18%
Protein Kinase B
18%
Therapeutic Effect
9%
Malignant Neoplasm
9%
Protein Tyrosine Kinase
9%
Methanol Extraction Residue
9%
Tumor Suppressor Protein
9%
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
Sorafenib
100%
Phosphoinositide 3-Kinase
18%
Protein Kinase B
18%
Signal Transduction
9%
Cell Migration
9%
RNA
9%
Tumor Suppressor Protein
9%
Cancer Cell
9%
Cell Invasion
9%
Receptor Tyrosine Kinase
9%
Immunology and Microbiology
Sorafenib
100%
Cancer Cell
9%
Hepatocellular Carcinoma Cell Line
9%
Cell Invasion
9%
Hepatology
9%
Methanol Extraction Residue
9%
Cell Migration
9%
Signal Transduction
9%
Tyrosine
9%